Clinical Trial Update: DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DEBIRI (irinotecan-eluting beads) plus standard chemotherapy versus chemotherapy alone in colorectal cancer liver metastases is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Cancer

Drugs mentioned

• DEBIRI (irinotecan-eluting beads) (irinotecan-eluting beads)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Liver Neoplasm, Colorectal Cancer Metastatic | Phase 3 | Status: RECRUITING